{"schema_version":"1.0","type":"article","title":"輝達殺進製藥業！BMS 搶 576 顆 GPU，禮來砸 10 億美元","url":"https://drugnews.com.tw/articles/2026-08-20-big-pharma-ai-arms-race-nvidia-bms-lilly.html","markdown_url":"https://drugnews.com.tw/articles/2026-08-20-big-pharma-ai-arms-race-nvidia-bms-lilly.md","lang":"zh-Hant","date":"2026-08-20","publish_at":"2026-08-20T08:00:00+08:00","updated_at":"2026-08-20","category":"商業分析系列","topic":"商業分析系列","tags":["AI 製藥","NVIDIA","BMS","禮來","Roche","新藥研發","GPU","台灣供應鏈"],"summary":"BMS 準備部署依 NVIDIA 規格推算共 576 顆 Rubin GPU，禮來與 NVIDIA 五年共同投入上限 10 億美元；真正的競爭不只在算力，而在能否把專有資料、濕實驗與臨床證據接成研發閉環。","key_points":[],"facts":[],"sections":["01｜BMS 一口氣補齊三層","02｜大藥廠買的是一整座研發工廠","03｜AI 跑得快，藥還是得過人體這一關","04｜台灣有位置，但別把供應鏈名單當訂單","寫在最後","參考資料","免責聲明"],"references":[{"title":"[Bristol Myers Squibb：建置 NVIDIA Vera Rubin AI factory]","source":"","date":"","url":"https://news.bms.com/news/corporate-financial/2026/Bristol-Myers-Squibb-to-Build-the-Most-Powerful-AI-Factory-in-Life-Sciences-with-NVIDIA/default.aspx"},{"title":"[NVIDIA：BMS 將部署 8 套 DGX Vera Rubin NVL72]","source":"","date":"","url":"https://blogs.nvidia.com/blog/bristol-myers-squibb-building-life-science-industrys-most-advanced-ai-factory-on-nvidia-vera-rubin/"},{"title":"[NVIDIA：DGX Vera Rubin NVL72 規格]","source":"","date":"","url":"https://www.nvidia.com/en-us/data-center/dgx-vera-rubin-nvl72/"},{"title":"[Bristol Myers Squibb：Claude Enterprise 導入逾 3 萬名員工]","source":"","date":"","url":"https://news.bms.com/news/corporate-financial/2026/Bristol-Myers-Squibb-Announces-Strategic-Agreement-with-Anthropic-to-Position-Claude-Enterprise-as-the-Shared-Intelligence-Platform-Across-Its-Global-Operations/default.aspx"},{"title":"[Schrödinger：Bunsen 分子研發代理人開放早期使用]","source":"","date":"","url":"https://ir.schrodinger.com/press-releases/news-details/2026/Schrdinger-Introduces-Bunsen-an-AI-Co-Scientist-for-Molecular-Discovery/default.aspx"},{"title":"[Eli Lilly：與 NVIDIA 建立五年最高 10 億美元共同創新實驗室]","source":"","date":"","url":"https://investor.lilly.com/news-releases/news-release-details/nvidia-and-lilly-announce-co-innovation-ai-lab-reinvent-drug"},{"title":"[Roche：新增 2,176 顆 Blackwell GPU]","source":"","date":"","url":"https://www.roche.com/media/releases/med-cor-2026-03-16"},{"title":"[Merck & Co.：與 Google Cloud 建立多年最高 10 億美元合作]","source":"","date":"","url":"https://www.merck.com/news/merck-and-google-cloud-partner-to-accelerate-agentic-ai-enterprise-transformation/"},{"title":"[Novo Nordisk：與 OpenAI 建立策略合作]","source":"","date":"","url":"https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916532"},{"title":"[Sanofi：投資 Owkin 並建立三年研究合作]","source":"","date":"","url":"https://www.sanofi.com/en/media-room/press-releases/2021/2021-11-18-06-30-00-2336966"},{"title":"[Nature Medicine：rentosertib IIa 期隨機對照研究]","source":"","date":"","url":"https://www.nature.com/articles/s41591-025-03743-2"},{"title":"[ClinicalTrials.gov：rentosertib NCT05938920]","source":"","date":"","url":"https://clinicaltrials.gov/study/NCT05938920"},{"title":"[MindRank：MDR-001 中國三期首位受試者給藥]","source":"","date":"","url":"https://www.mindrank.ai/en/news/detail/155"},{"title":"[Drug Discovery Today：AI-discovered drugs 臨床成功率回顧]","source":"","date":"","url":"https://pubmed.ncbi.nlm.nih.gov/38692505/"},{"title":"[NVIDIA：Vera Rubin 量產與台灣供應鏈夥伴]","source":"","date":"","url":"https://nvidianews.nvidia.com/news/vera-rubin-full-production-agentic-ai-factory"},{"title":"[NVIDIA：台灣 AI 基礎設施生態系]","source":"","date":"","url":"https://blogs.nvidia.com/blog/taiwan-ecosystem-ai-infrastructure/"},{"title":"查證截止日：2026 年 8 月 11 日。","source":"","date":"","url":""}],"images":[{"alt":"圖 1｜2026 年大藥廠 AI 軍備表；金額多為多年投入上限，設備規模不等於臨床成功","url":"https://drugnews.com.tw/assets/articles/big-pharma-ai-arms-race-nvidia-bms-lilly/figure-01.png"},{"alt":"圖 2｜AI 製藥從算力、代理人與濕實驗走到候選藥及臨床驗證；一期小樣本早期回顧不能外推上市成功率","url":"https://drugnews.com.tw/assets/articles/big-pharma-ai-arms-race-nvidia-bms-lilly/figure-02.png"},{"alt":"圖 3｜台灣位於 NVIDIA AI 基礎設施鏈上，但生態系關係不等於取得 BMS 或 Roche 的特定訂單","url":"https://drugnews.com.tw/assets/articles/big-pharma-ai-arms-race-nvidia-bms-lilly/figure-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/big-pharma-ai-arms-race-nvidia-bms-lilly/cover-1400.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-08-20）。輝達殺進製藥業！BMS 搶 576 顆 GPU，禮來砸 10 億美元。https://drugnews.com.tw/articles/2026-08-20-big-pharma-ai-arms-race-nvidia-bms-lilly.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-08-20-big-pharma-ai-arms-race-nvidia-bms-lilly-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}